24th Jun 2010 15:40
LONDON (Dow Jones)-- Petards Group Plc (PEG.LN), an AIM quoted developer of advanced security and surveillance systems, announced Thursday that despite the uncertainty relating to the outcome of the U.K. government's public spending review the anticipated results for 2010 remain in line with the Boa
Read more24th Jun 2010 12:12
LONDON (Dow Jones)--Water Hall Group PLC (WTH.LN), a holding company, said Thursday that its residual investment of 0.8 million shares in Lloyds Banking Group PLC (LLOY.LN) is regarded as non-core and it will therefore be sold at an opportune time. MAIN FACTS: -The U.K. planning system, esp
Read more21st Jun 2010 08:10
LONDON (Dow Jones)--Water Hall Group PLC (WTH.LN), which provides quarrying and waste management services, said Monday that at 1200 GMT on June 18, the tender offer to buy up to 104.5 million Ordinary shares in Petards Group PLC (PEG.LN) was over-subscribed by Petards shareholders. MAIN FACTS:
Read more19th May 2010 16:36
European concerns were behind sharp falls in shares today as plans by Germany to slap a ban on short-selling of European bonds, credit default swaps and ten of Germany's biggest financial groups spooked investors. German chancellor Angela Merkel's warning that Europe is facing its greatest crisis i
Read more19th May 2010 14:13
Leading shares trimmed their losses over the lunchtime session but the predominant colour on the Footsie leaderboard remains red. Mining companies lead the retreat on fears that Germany's decision to impose an immediate ban on "naked short selling" of euro-denominated government bonds and also cred
Read more19th May 2010 12:20
Water utility company Severn Trent was the only FTSE 100 constituent to advance during the morning session, as all of the others ended the morning underwater. If the move by Germany's financial regulator to impose an immediate ban on "naked short selling" of corporate debt last night was intended t
Read more19th May 2010 11:20
Underwriter Chaucer has reported a 3% dip in first quarter total gross written premium income to £250.1m, which KBC Peel Hunt said shows discipline. "Despite a high level of losses to the Chilean and Deepwater catastrophes in Q1, the tone of Chaucer's IMS is positive," said the broker. "The group i
Read more19th May 2010 10:29
Impax, the investment manager focused on environmental sector, saw its assets under management rise by 40% in the six months to March 31 as markets improved. 'Evidence of improving macroeconomic conditions, particularly in the United States and in the Asia-Pacific region, has resulted in continued
Read more26th Apr 2010 08:17
Shares in security and surveillance systems firm Petards jumped as it reported a 45% surge in full year pre-tax profit and said it remains confident for the future. Profit before tax rose to £1.0m for the year ended 31 December 2009 from £0.7m the same time a year before. "We are confident that t
Read more15th Dec 2009 09:05
Oil and gas engineering services firm Plexus Holdings has won a three year contract with a further two year option clause with Maersk Oil to supply its High Pressure/ High Temperature POS-GRIP wellhead technology. The value of the initial contract is estimated at £3m with revenues commencing in May
Read more19th Oct 2009 11:23
Shares in 21st Century Technology moved higher after the provider of CCTV cameras for public transport said it ad paid a final instalment of £500,000 for its acquisition of 21st Century Crime Prevention Services. Shares in Imagelinx jumped after the branding consultancy said will exceed profit for
Read more25th Sep 2009 08:43
Security and surveillance systems firm Petards saw profits drop for the half year but said the outlook for the second half is stronger with full year profits seen in line with expectations. Profit before tax was £242,000 against £305,000 in the same period last year on revenue that slumped to £6.6m
Read more29th Jul 2009 11:02
BTG shares rallied as its partner AstraZeneca confirmed its intention to progress severe sepsis treatment CytoFab into a Phase IIb study. This decision follows the successful completion by AstraZeneca of a Phase IIa study of CytoFab in 70 patients with severe sepsis. Arbuthnot Banking made a "satis
Read more